COVID-19 Vaccine Response in Chronic Respiratory Conditions

NCT05313087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2026-04-20

No results posted yet for this study

Summary

The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.

Conditions

  • SARS-CoV Infection

Interventions

BIOLOGICAL

COVID-19 vaccine

assess response to vaccine

Sponsors & Collaborators

  • National Jewish Health

    lead OTHER

Principal Investigators

  • Barry Make, MD · National Jewish Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05313087 on ClinicalTrials.gov